Resource Center
Emmes possesses deep experience in clinical research which we leverage on behalf of our clients. It is through our collaborative efforts with you that Emmes has conducted over 2,150 clinical trials and published 2,300+ peer-reviewed articles.
In this section of our site, we share our experience and publications with you as a tribute to our ongoing collaboration.
Resources
Publications
Clinical trials referral resource. Current clinical trials administering the antiangiogenesis agent SU5416
2000
Via, L.E., Gore-Langton, R.E., Pluda, J.M.
Clinical trials referral resource. Current clinical trials for the proteosome inhibitor PS-341
2000
Wright, J., Hillsamer, V.L., Gore-Langton, R.E., Cheson, B.D.
Clinical trials referral resource. Current clinical trials in prostate cancer
2000
Kaplan, R.S., Gore-Langton, R.E., Cheson, B.D.
Clinical trials referral source. Current clinical trials of the anti- CD20 monoclonal antibody rituximab
2000
Davis, T., Gore-Langton, R.E., Cheson, B.D.
Clinical trials resource. Treatment of advanced or recurrent squamous cell carcinoma of the head and neck
2000
Conley, B.A., Gore-Langton, R.E., Cheson, B.D.
Comparison of the safety, vaccine virus shedding and immunogenicity of influenza virus vaccine, trivalent, types A and B, live-cold-adapted (LAIV) administered to HIV-infected and non-HIV-infected adults
2000
King, J.C., Treanor, J., Fast, P.E., Wolff, M.C., Yan, L., Iacuzio, D., Readmond, B., O’Brien, D., Mallon, K., Highsmith, W.E., Lambert, J.S., Belshe, R.B.
Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eye drops
2000
Gahl, W.A., Kuehl, E.M., Iwata, F., Lindblad, A., Kaiser-Kupfer, M.I.
Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine
2000
Belshe, B.R., Gruber, W.C., Mendelman, P.M., Mehta, H.B., Cho, I., Mahmood, K., Reisinger, K., Treanor, J., Zangwill, K., Hayden, F.G., Bernstein, D.I., Kotloff, K., King, J., Piedra, P.A., Block, S.L., Yan, L., Wolff, M.
Cyclosporine to tacrolimus: rejection, toxicity and cardiovascular risks
2000
Copley, J., Staffeld, C., Lindberg, J., Bailey, C., Van Veldhuisen, P.